Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Gynaecological Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16398224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group.

  2004cited by this paper
• Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.

  2004cited by this paper
• Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.

  2004cited by this paper
• Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.

  2003cited by this paper
• Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.

  2003cited by this paper
• Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

  2003cited by this paper
• Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.

  2003cited by this paper
• Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.

  2003cited by this paper
• Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.

  2003cited by this paper
• Clear-cell and papillary serous cancer: treatment options.

  2001cited by this paper
• Treatment of uterine papillary serous carcinoma with paclitaxel.

  2001cited by this paper
• Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study.

  2001cited by this paper
• Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.

  2001cited by this paper
• Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy.

  2000cited by this paper
• Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.

  2000cited by this paper
• The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

  2000cited by this paper
• Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma.

  1999cited by this paper
• Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.

  1999cited by this paper
• The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.

  1999cited by this paper
• Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

  1998cited by this paper
• Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.

  1998cited by this paper
• Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.

  1998cited by this paper
• Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.

  1997cited by this paper
• Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.

  1996cited by this paper
• Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern

  1996cited by this paper
• A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.

  1996cited by this paper
• Endometrial carcinoma.

  1996cited by this paper
• Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

  1995cited by this paper
• Paclitaxel (taxol)

  1995cited by this paper
• Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases.

  1995cited by this paper
• Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma.

  1994cited by this paper
• Uterine papillary serous carcinoma: patterns of metastatic spread.

  1994cited by this paper
• Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).

  1993cited by this paper
• Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features

  1992cited by this paper
• Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

  1991cited by this paper
• Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early‐stage high‐risk endometrial cancer: A preliminary analysis

  1991cited by this paper
• Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

  1989cited by this paper
• Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma

  1982cited by this paper

• The importance of chemotherapy and radiation in uterine papillary serous carcinoma.

  2011cites this paper
• Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?

  2010cites this paper
• Controversies in the Management of Endometrial Cancer

  2010cites this paper
• Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.

  2009cites this paper
• Combined Chemotherapy Regimen of Carboplatin and Paclitaxel as Adjuvant Treatment for Papillary Serous and Clear Cell Endometrial Cancer

  2009cites this paper
• Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report

  2008cites this paper
• Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.

  2008cites this paper